Select Medical Holdings (NYSE: SEM) reported Q2 EPS of $0.61, $0.07 better than the analyst estimate of $0.54. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

Select Medical Holdings sees FY2023 EPS of $1.77-$1.94, versus the consensus of $1.92. Select Medical Holdings sees FY2023 revenue of $6.55-6.7 billion, versus the consensus of $6.589 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.